Home › Trial NCT03436485
Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer
- Trial IDNCT03436485
- StatusActive Not Recruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorOrion Corporation, Orion Pharma
- Enrollment204
- Start date2018-03-19
- ConditionsProstate Cancer Metastatic
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.